Other conditions may include liver disease, previously known as NASH now metabolic dysfunction-associated steatohepatitis (MASH), chronic kidney disease which can be caused by visceral adiposity in a manner similar to MASH and osteoarthritis due to reduced physical pressure on joints and reduced inflammation
Currently, common GLP-1 medications include tirzepatide (Mounjaro), semaglutide (Wegovy), and liragutide (Nevolat)
American Diabetes Association.
Eligible patients may significantly reduce their out-of-pocket cost when coverage is approved, but the insurer may require medical documentation before it agrees to pay
While the semaglutide pill is more affordable than the injection, and may be more convenient to take, its not right for every patient
Then, they check whether your plan even includes a weight-management pharmacy benefit